Cargando…

Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results

OBJECTIVE: This study evaluated the impact of daily ECG (electrocardiogram) self‐recordings on time to documented recurrent atrial fibrillation (AF) or atrial flutter (AFL) and time to treatment of recurrent arrhythmia in patients undergoing catheter radiofrequency ablation (RFA) or direct current c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldenthal, Isaac L., Sciacca, Robert R., Riga, Teresa, Bakken, Suzanne, Baumeister, Maurita, Biviano, Angelo B., Dizon, Jose M., Wang, Daniel, Wang, Ketty C, Whang, William, Hickey, Kathleen T., Garan, Hasan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819233/ https://www.ncbi.nlm.nih.gov/pubmed/31507001 http://dx.doi.org/10.1111/jce.14160

Ejemplares similares

Improving the utility and sustainability of novel health technology to improve clinical outcomes for patients: an East Staffordshire experience of screening for atrial fibrillation with the AliveCor KardiaMobile
por: Mathew, Savio, et al.
Publicado: (2021)

Comparison of Apple Watch vs KardiaMobile: A Tale of Two Devices
por: Lee, Calvin, et al.
Publicado: (2022)

Cardiac symptom burden and arrhythmia recurrence drives digital health use: results from the iHEART randomized controlled trial
por: Masterson Creber, Ruth M, et al.
Publicado: (2021)

Increasing Early Cardiac Screening in an Inpatient Psychiatric Setting Using the KardiaMobile 6 Lead Device
por: Pierscionek, Tomasz, et al.
Publicado: (2023)

Effectiveness of a single lead AliveCor electrocardiogram application for the screening of atrial fibrillation: A systematic review
por: Hall, Angela, et al.
Publicado: (2020)

Monitoring prolongation of QT interval in patients with multidrug-resistant tuberculosis and non-tuberculous mycobacterium using mobile health device AliveCor
por: Puranik, Shriya, et al.
Publicado: (2021)

Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients
por: Zaballos, Matilde, et al.
Publicado: (2023)

Single-lead ECGs (AliveCor) are a feasible, cost-effective and safer alternative to 12-lead ECGs in community diagnosis and monitoring of atrial fibrillation
por: Bray, Jonathan James Hyett, et al.
Publicado: (2021)

A single-center randomized, controlled trial investigating the efficacy of a mHealth ECG technology intervention to improve the detection of atrial fibrillation: the iHEART study protocol
por: Hickey, Kathleen T., et al.
Publicado: (2016)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Ibutilide for pharmacological cardioversion of atrial flutter
por: Magnusson, K, et al.
Publicado: (2002)

Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study
por: Ellins, Elizabeth A, et al.
Publicado: (2023)

Prolonged asystole following direct-current cardioversion for atrial flutter.
por: McMullan, R., et al.
Publicado: (2001)

Tolerance of High-Dose Oral Amiodarone for Cardioversion of Atrial Flutter
por: Le, Vincent K., et al.
Publicado: (2022)

Recurrent Atrial Flutter Requiring Multiple Cardioversions in a Preterm Infant
por: Jaile, Jesus C., et al.
Publicado: (2021)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
por: Mentias, Amgad, et al.
Publicado: (2021)

Inappropriate implantable cardioverter-defibrillator shocks in repaired tetralogy of fallot patients: Prevalence and electrophysiological mechanisms()
por: L.Goldenthal, Isaac, et al.
Publicado: (2020)

Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter
por: Wall, Christopher, et al.
Publicado: (2019)

Successful treatment of neonatal atrial flutter by synchronized cardioversion: case report and literature review
por: Wójtowicz-Marzec, Monika, et al.
Publicado: (2020)

Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter
por: Malviya, Amit, et al.
Publicado: (2020)

Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center
por: Koltowski, Lukasz, et al.
Publicado: (2021)

DC cardioversion of atrial fibrillation and atrial flutter in the emergency department: improving specialist protocols for the generalist
por: Carpenter, Alexander, et al.
Publicado: (2018)

Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation
por: Wybraniec, Maciej T., et al.
Publicado: (2023)

A new LMS algorithm for analysis of atrial fibrillation signals
por: Ciaccio, Edward J, et al.
Publicado: (2012)

Identification of recurring patterns in fractionated atrial electrograms using new transform coefficients
por: Ciaccio, Edward J, et al.
Publicado: (2012)

Improved frequency resolution for characterization of complex fractionated atrial electrograms
por: Ciaccio, Edward J, et al.
Publicado: (2012)

Parsing a perplexing paroxysmal pathway
por: Wan, Elaine, et al.
Publicado: (2015)

Croatia needs a registry of patients undergoing direct current cardioversion for persistent atrial fibrillation/flutter
por: Dubravčić, Mia, et al.
Publicado: (2016)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center
por: Arshad, Samiullah, et al.
Publicado: (2022)

A new transform for the analysis of complex fractionated atrial electrograms
por: Ciaccio, Edward J, et al.
Publicado: (2011)

A Nurse-led Approach to Improving Cardiac Lifestyle Modification in an Atrial Fibrillation Population
por: Hickey, Kathleen T., et al.
Publicado: (2019)

Kardia Mobile and ISTEL HR applicability in clinical practice: a comparison of Kardia Mobile, ISTEL HR, and standard 12-lead electrocardiogram records in 98 consecutive patients of a tertiary cardiovascular care centre
por: Krzowski, Bartosz, et al.
Publicado: (2021)

Risk factor management of atrial fibrillation using mHealth: The Atrial Fibrillation – Helping Address Care with Remote Technology (AF-HEART) Pilot Study
por: Mitrani, Lindsey R., et al.
Publicado: (2021)

The comparison of Kardia Mobile and Hartmann Veroval 2 in 1 in detecting first diagnosed atrial fibrillation
por: Zaprutko, Tomasz, et al.
Publicado: (2023)

Getting to the right left atrium: Catheter ablation of atrial fibrillation and mitral annular flutter in cor triatriatum
por: Borne, Ryan T., et al.
Publicado: (2016)

Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials
por: Thind, Munveer, et al.
Publicado: (2020)

Cockles and Mussels; Alive, Alive Oh!
Publicado: (1903)

Alive
por: Jean-Dit-Pannel, Lydie
Publicado: (2010)

Alive
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_gjdpom726gtafka748m7gsdhuf